| Name | Title | Contact Details |
|---|
Humanscale is the premier designer and manufacturer of sustainable, high-performance ergonomic products for the workplace. Our award-winning solutions improve the health, efficiency and quality of work life. Since its founding in 1983, Humanscale has held the belief that design based on functionality and ease of use results in honest and enduring forms. Humanscale`s simple, elegant solutions stand the test of time—both functionally and aesthetically—while consuming as little of the Earth`s limited resources as possible. Nearly every Humanscale product can contribute to the achievement of LEED-CI, -NC and -EB credits. In addition to manufacturing premier ergonomic work tools, Humanscale`s team of certified ergonomists is available to help organizations further improve worker comfort, reduce injuries, and boost productivity through ergonomic assessments, training, and program development. With headquarters in New York City, Humanscale`s showrooms, offices and manufacturing facilities are strategically located throughout North America, Europe, Asia and Australia, while a worldwide network of esteemed distributors enables Humanscale solutions to reach every corner of the globe.
Medrecon is a Garwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.
Z-Sciences Corp is a Westmount, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Linet Americas is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.